Civmec Limited
Civmec Limited (CVL.AX) Financial Performance & Income Statement Overview
Analyze Civmec Limited (CVL.AX) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Civmec Limited (CVL.AX) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Civmec Limited CVL.AX financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $270.29M | $271.09M | $245.17M | $246.93M |
| Cost of Revenue | $240.95M | $241.67M | $215.15M | $216.69M |
| Gross Profit | $29.34M | $29.43M | $30.02M | $30.24M |
| Gross Profit Ratio | $0.11 | $0.11 | $0.12 | $0.12 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $6.09M | $6.11M | $6.29M | $6.33M |
| Operating Expenses | $6.09M | $6.11M | $6.29M | $6.33M |
| Total Costs & Expenses | $247.03M | $247.77M | $221.44M | $223.02M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $4.91M | $4.93M | $4.90M | $4.93M |
| EBITDA | $27.64M | $27.72M | $27.89M | $28.09M |
| EBITDA Ratio | $0.10 | $0.10 | $0.11 | $0.11 |
| Operating Income | $23.25M | $23.32M | $23.74M | $23.91M |
| Operating Income Ratio | $0.09 | $0.09 | $0.10 | $0.10 |
| Other Income/Expenses (Net) | -$89409.00 | -$89676.00 | -$1.27M | -$1.28M |
| Income Before Tax | $23.16M | $23.23M | $22.47M | $22.63M |
| Income Before Tax Ratio | $0.09 | $0.09 | $0.09 | $0.09 |
| Income Tax Expense | $6.92M | $6.94M | $6.59M | $6.63M |
| Net Income | $16.24M | $16.29M | $15.88M | $16.00M |
| Net Income Ratio | $0.06 | $0.06 | $0.06 | $0.06 |
| EPS | $0.03 | $0.03 | $0.03 | $0.03 |
| Diluted EPS | $0.03 | $0.03 | $0.03 | $0.03 |
| Weighted Avg Shares Outstanding | $512.87M | $512.87M | $511.94M | $511.94M |
| Weighted Avg Shares Outstanding (Diluted) | $512.89M | $512.89M | $512.07M | $512.07M |
Over the past four quarters, Civmec Limited demonstrated steady revenue growth, increasing from $246.93M in Q1 2024 to $270.29M in Q4 2024. Operating income reached $23.25M in Q4 2024, maintaining a consistent 9% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $27.64M, reflecting operational efficiency. Net income dropped to $16.24M, with EPS at $0.03. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan